Aspergillus nidulans is able to use Leu as the sole carbon source through a metabolic pathway leading to acetyl-CoA and acetoacetate that is homologous to that used by humans. mccA and mccB, the genes encoding the subunits of 3-methylcrotonyl-CoA carboxylase, are clustered with ivdA encoding isovaleryl-CoA dehydrogenase, a third gene of the Leu catabolic pathway, on the left arm of chromosome III. Their transcription is induced by Leu and other hydrophobic amino acids and repressed by glucose. Phenotypically indistinguishable ⌬mccA, ⌬mccB, and ⌬mccA ⌬mccB mutations prevent growth on Leu but not on lactose or other amino acids, formally demonstrating in vivo the specific involvement of 3-methylcrotonyl-CoA carboxylase in Leu catabolism. Growth of mcc mutants on lactose plus Leu is impaired, indicating that Leu metabolite(s) accumulation resulting from the metabolic block is toxic. Human patients carrying loss-of-function mutations in the genes encoding the subunits of 3-methylcrotonyl-CoA carboxylase suffer from methylcrotonylglycinuria. Gas chromatography/mass spectrometry analysis of culture supernatants revealed that fungal ⌬mcc strains accumulate 3-hydroxyisovaleric acid, one of the diagnostic compounds in the urine of these patients, illustrating the remarkably similar consequences of equivalent genetic errors of metabolism in fungi and humans. We use our fungal model(s) for methylcrotonylglycinuria to show accumulation of 3-hydroxyisovalerate on transfer of 3-methylcrotonyl-CoA carboxylase-deficient strains to the isoprenoid precursors acetate, 3-hydroxy-3-methylglutarate, or mevalonate. This represents the first reported genetic evidence for the existence of a metabolic link involving 3-methylcrotonyl-CoA carboxylase between isoprenoid biosynthesis and Leu catabolism, providing additional support to the mevalonate shunt proposed previously (Edmond, J., and Popjá k, G. (1974) J. Biol. Chem. 249, 66 -71).
In humans, Leu is a ketogenic amino acid that is converted to acetyl-CoA through a six-step pathway (1) (see Fig. 1 ). The first step in this pathway is catalyzed by the branched chain amino acid (BCAA) 1 transaminase, which appears to act on all three BCAAs (Leu, Ile, and Val) to yield the corresponding branched chain ketoacids (BCKAs). All three ketoacids are substrates of the BCKA dehydrogenase complex, which catalyzes their oxidative decarboxylation to the respective Ϫ1 acyl-CoA derivatives ( Fig. 1 , step II, isovaleryl-CoA in the case of Leu catabolism). Isovaleryl-CoA is oxidized to acetyl-CoA and acetoacetate through four additional steps specific for Leu catabolism ( Fig.  1 , steps III-VI) (2) .
Individuals deficient for any of the six enzymes of this pathway have a clinical phenotype (see Fig. 1 ). For example, inborn errors of metabolism resulting from loss-of-function mutations in any of the structural genes encoding subunits of the BCKA dehydrogenase complex lead to maple syrup urine disease, a severe, not infrequent panethnic recessive disorder (2) . However, despite the clinical relevance of this pathway, the molecular basis of two enzyme deficiencies in Leu catabolism had not been established when this work was started. These were the deficiencies of 3-methylcrotonyl-CoA carboxylase (MCC; EC 6.4.1.4), resulting in 3-methylcrotonylglycinuria (OMIM 210200), and 3-methylglutaconyl-CoA hydratase (EC 4.2.1.18), resulting in type I 3-methylglutaconic aciduria (OMIM 250950). Whereas the characterization of the 3-methylglutaconyl-CoA hydratase-mediated step will be the subject of another paper, this paper describes the genetic and biochemical characterization of the MCC-mediated step in Aspergillus nidulans. The derived amino acid sequences of the fungal MCC subunits were instrumental for our identification of their human homologues and subsequent characterization of the molecular basis of the disease (3), which was simultaneously reported by Baumgartner et al. (4) .
The mitochondrial enzyme MCC is, with propionyl-CoA carboxylase (PCC), pyruvate carboxylase (PC), and acetyl-CoA carboxylase (ACC), one of the four biotin-dependent carboxylases in humans. All four enzymes share a biotin carrier domain carrying the covalently bound prosthetic group, a biotincarboxylating domain, and a carboxyltransferase domain catalyzing carboxyl group transfer from carboxybiotin to the specific substrate. In the current model (5) , the biotin carrier domain acts as a swinging arm oscillating between the biotin carboxylase and the carboxyltransferase domains of the enzyme. As PCC, MCC is a heterodimeric enzyme consisting of ␣ and ␤ subunits in an (␣␤) 6 configuration (6), whose correspond-ing genes were first characterized in plants (7, 8) . MCC␣ contains the biotin-carboxylating and biotin carrier domains, and MCC␤ contains the carboxyltransferase domain (3, 4, (7) (8) (9) .
The metabolically versatile fungus A. nidulans is able to use most amino acids as the sole carbon source through catabolic pathways homologous to those used by human hepatocytes (10, 11) (this work). High level expression of genes for an amino acid catabolic pathway usually requires their induction by the corresponding pathway substrate, and their transcription is low or undetectable in its absence, which facilitates the cloning of the corresponding cDNAs using subtractive procedures (10 -13) or cDNA libraries from cells cultured under inducing conditions (this work). Amino acid catabolic genes are often clustered (10 -13) (this work), which, with the small average intron size (less than 100 bp), facilitates the molecular genetic characterization of the pathways. The fungus has a relatively compact, haploid genome of only 31 Mb (complete sequence available on the World Wide Web at www-genome.wi.mit.edu). Haploidy, the absence of significant gene redundancy, and the relative ease with which A. nidulans can be manipulated by reverse genetics facilitate gene inactivation by homologous recombination/gene replacement, using a relatively rapid procedure. Mutations can be recombined using the sexual cycle, which is completed within 2 weeks. Last, the fungus can be cultured in a chemically defined medium containing inorganic salts and sole nitrogen and carbon sources, which can be changed as appropriate, permitting normal growth of mutants deficient in amino acid catabolic pathways by using alternative carbon sources, such as carbohydrates. These advantages over human cell cultures are extensively exploited in this work.
In addition to its role in Leu catabolism, MCC has been proposed to be involved in a shunt pathway by which mevalonate-derived isopentenyl pyrophosphate is converted to mitochondrial 3HMG-CoA (Fig. 1 ). This pathway is of notable interest because it might divert isoprene units from cholesterol biosynthesis (14) . However, evidence supporting a physiological role for this pathway is solely based on tracer studies using radioisotope-labeled mevalonate (for a review, see Ref. 14). Here we describe the molecular and biochemical characterization of A. nidulans genes encoding subunits of MCC and the construction of fungal models for MCC deficiency. Strains carrying null mutations in the genes encoding MCC subunits were used to demonstrate unambiguously the in vivo involvement of this enzyme in Leu catabolism. Biochemical characterization of these strains illustrates further the similar metabolic consequences caused by homologous amino acid degradation enzyme deficiencies in fungi and humans. Finally, we exploit these models and the ease with which the composition of the A. nidulans growth medium can be manipulated à la carte to provide genetic evidence of the presence of a metabolic link between isoprenoid biosynthesis and Leu catabolism involving MCC.
EXPERIMENTAL PROCEDURES
Fungal Strains, Media, and Growth Conditions-A. nidulans strains carried markers in standard use (15). Complete and minimal media were as in Ref. 16 . Lactose was used at 0.05% (w/v) as the sole carbon source, and amino acids were used at 30 mM, unless otherwise indicated.
RNA Isolation-7 ϫ 10 6 conidiospores/ml were inoculated on minimal medium containing 0.3% (w/v) glucose as carbon source and 5 mM ammonium tartrate as nitrogen source. Primary cultures were incubated at 37°C. When the glucose concentration fell below 0.01%, mycelia were transferred to 5 mM urea minimal medium without any carbon source and incubated for a further 1 h before adding an appropriate carbon source. These secondary cultures were incubated for a further 3 h before collecting mycelia for RNA extraction. Mycelia were frozen in liquid nitrogen; ground to fine powder; resuspended in 6 M FIG. 1. The leucine degradation pathway and the mevalonate shunt. Shown are enzymes for Leu catabolism in Aspergillus and humans, with other possible pathways involving 3-methylcrotonyl-CoA carboxylase. Enzyme deficiencies in Leu catabolism cause the following diseases: hypervalinemia/hyperleucine-isoleucinemia (I); maple syrup urine disease (II); isovaleric acidemia (III); isolated 3-methylcrotonyl-CoA carboxylase deficiency, methylcrotonylglycinuria (IV); methylglutaconic aciduria, type 1 (V); and 3-hydroxy-3-methylglutaric aciduria (VI). The isoprenoid biosynthetic pathway is schematized on the right, with an indication of proposed intermediates of the mevalonate shunt (see "Discussion"). Geranoyl-CoA degradation could be another possible link between isoprenoid metabolism and the Leu degradation pathway. guanidine hydrochloride, 0.1 mM dithiothreitol, and 20 mM sodium acetate, pH 5.0; and incubated for 10 min at 0°C. This suspension was spun at 10,000 rpm and 4°C for 10 min in a SS-34 rotor, and nucleic acids in the supernatant were recovered by ethanol precipitation. Nucleic acids were resuspended in 20 mM EDTA, pH 8.0, and the RNA was precipitated with 3 volumes of 4 M sodium acetate for 1 h at Ϫ20°C and recovered after centrifugation in a refrigerated microcentrifuge. RNA was resuspended in RNase-free water, reprecipitated with ethanol, and stored in water at Ϫ80°C.
Probes for Genomic Library Screens and Northern Blot AnalysisThe screens of the genomic library were carried out using PCR-amplified DNA fragments obtained from genomic DNA (mccA) or from A. nidulans ESTs n01c10 (mccB) (available on the World Wide Web at bioinfo.okstate.edu/pipeonline/). In Northern blots, the EST n01c10 insert was also used as an mccB-specific probe, the mccA probe was a PCR fragment containing the complete mccA coding sequence, and the ivdAspecific probe included its coding region between codon 69 and the stop codon.
Genomic and cDNA Libraries-The A. nidulans genomic library was a standard EMBL4 library constructed from a Glasgow wild-type strain. mRNA used to construct the cDNA library was obtained from mycelia cultured in the presence of 30 mM Leu as the sole carbon source, which strongly induces transcription of Leu catabolism genes. After oligo(dT) selection of messenger RNA, double-stranded cDNA was synthesized using the SMART TM technique (Clontech), ligated into SfiIdigested TriplEx2 phagemid arms, and packed in vitro using Stratagene Gigapack II Plus extracts. The primary library contained 1.5 ϫ 10 6 recombinant clones, with an average insert size of 1.39 kbp.
Transformation-To construct ⌬mccA and ⌬mccB mutants, strains MAD003 biA1 methG1 argB2 and MAD559 yA2 pabaA1 argB2 pyrG89 riboB2 were used as recipient strains in transformation experiments (17) , respectively. Southern blot analysis with mccA-and argB-specific probes or mccB-and pyr-4-specific probes was used to confirm the expected deletion events in ⌬mccA and ⌬mccB strains, respectively.
Enzyme Assays-These were carried out essentially as described (18) , by determining the amount of Reactions were started by the addition of 300 M 3-methylcrotonyl-CoA. After a 7-min incubation at 30°C, they were stopped by the addition of 0.1 ml of 6 N HCl. Samples were microcentrifuged for 15 min at 14,000 rpm, and aliquots of the supernatant were spotted on Whatman 3MM paper, dried, and counted in a liquid scintillation counter.
GC/MS Analysis of Culture Supernatants-Fungal mycelia were precultured as described for RNA isolation and transferred to minimal medium with one of the following carbon sources: 0.05% (w/v) lactose, 3 mM Leu, 10 mM Ile, 100 mM sodium acetate, 30 mM 3-hydroxy-3-methylglutaric acid, or 30 mM DL-mevalonate. Secondary cultures were incubated for a further 21 h. Culture supernatants were collected after removing mycelia by filtration. After the addition of 0.1 mM (final concentration) phenylacetate (which was used as an internal control for extraction of organic acids), culture supernatants were acidified to pH Ͻ2 with 6 N HCl in the presence of saturating NaCl and extracted with isobutylacetate. The organic phase was dried under nitrogen and derivatized with bis(trimethylsilyl)trifluoroacetamide. Trimethylsilyl derivatives were analyzed in a 5% phenylmethylsilicone column (30 m ϫ 0.25 mm; 0.25-M film thickness), using an HP 5890 Series II gas chromatograph and an HP 5971 mass spectrometer, with the following temperature program. After 5 min at 70°C, the temperature was raised to 300°C (4.5°C/min) and kept at this limit for a further 5 min. Identification of peaks was carried out with the ChemStation software of Hewlett Packard.
RESULTS
Previous work showed that Leu is able to support A. nidulans vegetative growth and conidiation when used as the sole carbon source, although both growth strength and conidiation density were notably reduced on a range of Leu concentrations as compared with more favorable carbon sources. Supplementation of the medium with pyridoxine or thiamine (the cofactors of BCAA transaminase and BCKA dehydrogenase, respectively) did not improve either to any significant extent, indicating that cofactor biosynthesis is not limiting. Thus, unless otherwise indicated (see GC/MS analysis below), we routinely used Leu at 30 mM for growth tests and induction of the synthesis of Leu catabolic enzymes.
Molecular Characterization of Fungal Genes Encoding Subunits of 3-Methylcrotonyl-CoA
Carboxylase-Fungal candidate cDNAs for MCCA and MCCB were identified by in silico screening of the University of Oklahoma A. nidulans EST data base (available on the World Wide Web at www.genome.ou.edu/ fungal.html) using the deduced Arabidopsis thaliana ␣-and ␤-MCC and human ␣-and ␤-PCC amino acid sequences in TBLASTN searches (3) . PCR-derived DNA probes, based on the nucleotide sequences of candidate ESTs, were obtained and used to screen A. nidulans genomic (in EMBL4) and cDNA (from inducing growth conditions; see below) libraries. The genomic screen revealed, in addition to phage clones hybridizing only to MCC␣-or MCC␤-specific probes, a third class of clones cross-hybridizing to both, which strongly suggested that A. nidulans candidate genes encoding MCC␣ and MCC␤, which we denoted mccA and mccB, respectively, are physically linked. Restriction enzyme mapping and nucleotide sequencing of an ϳ15-kb A. nidulans genomic DNA region reconstructed with overlapping bacteriophage clone inserts in this third class revealed that this is indeed the case. mccA and mccB open reading frames are divergent, with their predicted initiation Met codons separated by 3692 bp.
A cDNA library made from mRNA isolated from cells grown in the presence of Leu as the sole carbon source (a condition inducing transcription of Leu catabolic genes; see below) was screened to isolate full-length mccA and mccB cDNAs, which were used to determine intron/exon borders after comparison of genomic and cDNA sequences. The 2688-bp mccA gene (GenBank TM accession number AY387592) is split by three introns ranging from 44 to 309 bp, whereas the 1843-bp mccB gene (GenBank TM accession number AY387593) is split by a single 80-bp intron.
The mccA cDNA encodes a 763-residue MccA polypeptide that shows 40% amino acid sequence identity to Arabidopsis and human MCC␣. Triple (fungal, plant, and human) MCC␣ alignment (not shown) showed that patches of amino acid sequence conservation predominate in the NH 2 -terminal twothirds of the protein and in the ϳ65-residue C-terminal domain containing the biotinylation motif, whereas the sequence separating these regions (residues 480 -640 in A. nidulans MccA) does not contribute to sequence conservation. Near the C terminus of MccA there is a 668 SMKM 671 tetrapeptide biotin binding motif found in biotin-dependent carboxylases (19) , where the ⑀-amino group of Lys-670 is predicted to bind the cofactor covalently through an amide bond. In addition, A. nidulans , which is completely conserved among Aspergillus, Arabidopsis, and human MCC␣ polypeptides and strongly conserved among biotin-dependent carboxylases. The structure of bacterial acetyl-CoA carboxylase revealed that this peptide makes a major contribution to ATP binding (20) .
The mccB cDNA encodes a 567-residue MccB polypeptide showing 59 and 51% amino acid sequence identity to human and Arabidopsis MCC␤, respectively. MccB contains a putative acyl-CoA binding motif (21, 22) within residues 354 and 392, which is strongly conserved among MCC␤ subunits and less so among biotin-dependent carboxylases, possibly reflecting the differing substrate specificities of these enzymes. In agreement with substrate specificities residing in the ␤ chains of heterodimeric biotin-dependent carboxylases, MccB and PCC␤ are markedly more dissimilar in amino acid sequence than the MccA/PCC␣ pair (data not shown).
Transcriptional Regulation of mccA and mccB-Northern analysis of mycelia precultured under glucose-limiting condi-tions and transferred to media with different carbon sources revealed that mccA and mccB show a similar transcription pattern, in agreement with these genes encoding subunits of a heterodimeric enzyme (Fig. 2) . Basal transcript levels, comparable with those observed in the absence of carbon source, were detected in the presence of acetate (a gluconeogenic C source) but also in the presence of Thr, Glu, Pro, or Trp (Fig. 2, lanes  1-4 and 9) . In marked contrast, BCAAs (Leu, Ile, and Val), Phe, and Met resulted in strong, similar induction of mccA and mccB transcription (Fig. 2, lanes 5-8 and 12 ). Transcription was repressed by glucose to nearly undetectable levels, even in the presence of an inducing amino acid (Fig. 2, lanes 10 and 11) . These findings agree with the predicted role of mccA and mccB in the Leu degradation pathway.
In A. nidulans, pathway-specific transcription factors of the zinc binuclear cluster family (23, 24) control expression of structural genes for catabolic pathways. These factors are typically positively acting regulatory proteins whose action absolutely requires induction by the pathway substrate. Therefore, the above results suggest that one such pathway-specific transcriptional activator, whose action requires induction by Leu or certain other hydrophobic amino acids such as Met and Phe, is required for full expression of mccA and mccB. The negative effect of glucose on transcript levels suggests that transcription is carbon catabolite-repressible. The regulatory proteins mediating induction and repression of genes in the Leu catabolic pathway have not been investigated further.
A Three-gene Cluster Mediating Two Sequential Steps in the Leu Degradation Pathway-mccA and mccB are located within contig 80 (nt positions 69,585-71,752) on the left arm of chromosome III (available on the World Wide Web at wwwgenome.wi.mit.edu/annotation/fungi/aspergillus) (Fig. 3) . Fig.  3 also depicts the relative position of sC encoding ATP sulfurylase, which is the closest (at ϳ250 kb) gene to mccA that has been functionally characterized (25) . mccA and mccB are flanked by genes that almost certainly are not involved in Leu catabolism. Centromere distal from mccA (see Fig. 3 ) is arbD, a gene encoding a 290-residue protein showing high amino acid sequence identity to Candida albicans D-arabitol dehydrogenase. Centromere-proximal from mccB and separated from it by an 822-bp intergenic region is a gene predicted to encode a chitosanase, denoted csnA (Fig. 3) . Similar csnA transcript levels were found on glucose, Leu, or a mixture of glucose and Leu (Fig. 3) , as expected for a gene that is not involved in Leu catabolism. In contrast, Northern analysis using a probe containing the region between mccA and mccB revealed the presence of a third gene whose transcription is Leu-inducible and glucose-repressible, strongly suggesting that this region contains another gene of the Leu catabolic pathway, that was denoted ivdA (GenBank TM accession number AY387594). Sequence analysis of ivdA cDNA clones revealed that the gene is split by three introns and that its transcript encodes a 430-residue protein showing high amino acid sequence identity to isovaleryl-CoA dehydrogenase (IVD) enzymes (55 and 63% to human and Pseudomonas aeruginosa IVD, respectively). IVD (EC 1.3.99.10) catalyzes conversion of isovaleryl-CoA to 3-methylcrotonyl-CoA with formation of FADH 2 (Fig. 1) . The divergently transcribed mccB and ivdA genes are separated by an intergenic region of 385 bp (Fig. 3) . We conclude that this region of chromosome III contains a three-gene cluster encoding two sequentially acting enzymes of the Leu degradation pathway.
Construction and Phenotypic Characterization of ⌬mccA and ⌬mccB Alleles-Null ⌬mccA and ⌬mccB alleles were constructed by transformation, using a gene replacement procedure. The mccA transcription start and polyadenylation sites are located at Ϫ31 (relative to the initiation codon) and ϩ89 (relative to the stop codon), respectively. To construct a null ⌬mccA allele, a 5423-bp DNA fragment in which sequences from Ϫ14 (relative to the ATG) to ϩ3 (relative to the stop codon) had been substituted by a 3133-bp DNA fragment containing the argB ϩ gene was used to transform an argB2 arginine-requiring strain (Fig. 4A ). Prototrophic transformants were purified on minus-arginine minimal medium. Of these, ϳ15% were unable to grow on leucine as a sole carbon source. All 10 transformants unable to grow on leucine that were analyzed by Southern blotting showed the hybridization pattern expected for the double crossover event shown in Fig. 4A and were therefore carrying the ⌬mccA allele. Two, chosen for further analysis, were phenotypically indistinguishable in that they showed wild type growth on lactose, Ile, Phe, Pro, Thr, or Val, but their growth was severely reduced on Leu minimal medium as compared with the wild type (data not shown) (3) . Northern blot analysis of mRNA isolated from cells grown under leucine-inducing conditions revealed that, in agreement with the complete deletion of the gene, the ⌬mccA mutation indeed results in undetectable levels of the mccA transcript, whereas levels of the ivdA transcript remain essentially unaffected (Fig. 5) . As expected from Northern analysis, enzyme assays showed that the ⌬mccA mutation nearly abolishes MCC activity (Table I ).
An apparently full-length mccB cDNA starting 39 bp upstream from the initiation codon that is polyadenylated 57 bp downstream from the stop codon was characterized. To construct a null ⌬mccB allele, a 5624-bp DNA fragment in which sequences from Ϫ21 (relative to the ATG) to ϩ62 (relative to the stop codon) had been substituted by a ϳ3200-bp DNA fragment containing the Neurospora crassa pyr-4 gene was used to transform a pyrG89 pyrimidine-requiring strain ( Northern analysis of mccA and mccB. Mycelia were grown in minimal medium with 0.3% (w/v) glucose as the sole carbon source for 16 h at 37°C and transferred to media with the indicated carbon sources, where amino acids were used at 30 mM, glucose (Gluc) was used at 1% (w/v), and acetate (AcH) was used at 100 mM. ϪC, medium with no carbon source added. After a 3-h additional incubation of these secondary cultures, mycelia were harvested and used to isolate RNA, which was analyzed by Northern blotting, using mccA-or mccB-specific probes, as indicated. Actin was used as a loading control. growth tests as described above. As with ⌬mccA strains, two transformants showing the expected hybridization pattern for a mccB deletion event were phenotypically indistinguishable, being unable to grow on Leu as the sole carbon source, although they grew as the wild type on lactose, Ile, Phe, Thr, and Val (Fig. 4C) . ⌬mccB results in undetectable mccB transcript levels and, like ⌬mccA, it does not affect ivdA transcription (Fig. 5 ) and abolishes MCC activity (Table I) .
A double ⌬mccA ⌬mccB mutant was constructed after crossing the corresponding single mutants. As expected, whereas single mutants abolished transcription only of the corresponding deleted gene, the double ⌬mccA ⌬mccB mutation abolished transcription of both but had no major effect on ivdA (Fig. 5) . As single ⌬mccA or ⌬mccB mutants (see below), ⌬mccA ⌬mccB strains showed residual growth on Leu, similar to that observed on agar plates lacking an added carbon source. In enzyme assays (Table I) , the double mutant showed the same nearly null levels of activity than either of the single mutants. Therefore, ⌬mccA, ⌬mccB, and ⌬mccA ⌬mccB strains are phenotypically identical.
The inability of ⌬mccA, ⌬mccB, or ⌬mccA ⌬mccB strains to use Leu as the sole carbon source demonstrates the in vivo Fig. 2 ) using the indicated probes. Equal loading was confirmed by hybridization with an actinspecific probe, as in Fig. 2.   FIG. 4 . Constructing null mccA and mccB alleles. A, strategy for deleting mccA. B, strategy for deleting mccB. For A and B, EcoRI sites are indicated by E. The relative position of genes within the cluster should be consulted in Fig. 3 . Detailed coordinates are given under "Results." C, growth phenotype of a ⌬mccB strain on the indicated carbon sources, compared with the wild type. Valine is a very poor carbon source. The phenotype of the ⌬mccA mutant has been published elsewhere (3) and is identical to that of the ⌬mccB mutant shown here. involvement of MCC in Leu catabolism.
Fungal Model for 3-Methylcrotonyl-CoA Carboxylase Deficiency-Patients suffering from isolated MCC deficiency excrete in their urine markedly elevated amounts of 3-hydroxyisovaleric acid (3-HIVA) and 3-methylcrotonylglycine (3-MCGly), which are diagnostic biochemical markers of the disease (Fig. 6, A and B) (1, 26) . A. nidulans can be grown on synthetic medium containing Leu as the sole carbon source. If an amino acid degradation pathway is blocked by a loss-offunction structural gene mutation, metabolites accumulating as a result of the enzyme deficiency exit the cell and appear in the culture supernatant, which, analogously to human urine, can be analyzed by GC/MS (11, 13) . In contrast to the wild type, ⌬mccA ⌬mccB cells accumulate 3-HIVA in a leucine-dependent manner, as expected form the specific involvement of MCC in Leu catabolism. Fig. 6 , E-H, shows that the GC/MS profile of supernatants from wild type and ⌬mccA ⌬mccB cultures is virtually indistinguishable when cells were incubated in synthetic medium containing lactose or isoleucine as sole carbon source. In contrast, a marked accumulation of 3-HIVA was detected when the double mutant but not the wild type was cultured in medium containing leucine as the sole carbon source (Fig. 6, C and D) . This marked accumulation of 3-HIVA was also detected using ⌬mccA or ⌬mccB single mutants (data not shown). Of note, 3-MCGly was detected in neither.
The specific accumulation of 3-HIVA upon culturing MCCdeficient fungal cells in Leu medium illustrates the remarkable similarity of the metabolic consequences of equivalent enzyme deficiencies in human and fungi. As in humans, 3-HIVA almost certainly results from hydration of 3-methylcrotonyl-CoA by crotonase (enoyl-CoA hydratase) followed by spontaneous deacylation (1). Although A. nidulans enzymes with enoyl-CoA hydratase activity have not yet been functionally characterized, the A. nidulans genome contains an almost certain candidate gene to encode such a protein. 2 In contrast, the human plasma Gly-conjugating enzyme converting organic acids to their corresponding glycine amides would appear to be absent from A. nidulans.
2-Hydroxy-3-methylvaleric acid (2H3MV) resulting from hydration of ␣-keto-␤-methylvaleric acid, the product of Ile transamination, accumulates in the culture supernatants of both the wild type and the MCC-deficient mutant grown in minimal medium with 10 mM Ile as the sole carbon source. This indicates that, as in humans (27) , BCKA dehydrogenase activity is limiting under these conditions. BCKA dehydrogenase catalyzes the oxidative decarboxylation of all three BCAA transamination products. In agreement, a marked elevation of 2-hydroxyisocaproic acid resulting from hydration of ␣-ketoisocaproic acid, the Leu transamination product (Fig. 1) , was seen when the Leu concentration in fungal cultures was raised to 10 mM or above (data not shown). It is worth noting that also in humans, ␣-ketoisocaproic acid decarboxylation is the rate-limiting step in Leu catabolism.
Whereas MCC-deficient strains grow normally on lactose, ⌬mccA or ⌬mccB mutations impair growth on lactose plus leucine to a significant extent, indicating that 3-HIVA and/or other metabolites accumulating in the deficient strains are toxic (Fig. 7) . Since A. nidulans is an aerobe, such toxicity could reflect an impairment of mitochondrial function by these metabolites.
The Mevalonate Shunt-The biosynthetic cholesterol pathway proceeds via mevalonate formed by 3HMG-CoA reductase. Metabolic tracing studies showed that not all mevalonate is converted to sterols and strongly supported the existence of a link between the cholesterol biosynthetic pathway and Leu catabolism (see Refs. 14 and 28 -30 and references therein). Edmond and Popjá k (29) proposed that mevalonate is converted to acetyl-CoA via the enzymes of the Leu catabolic pathway after its conversion to 3-methylcrotonyl-CoA by the shunt pathway shown in Fig. 1 . Another possible link is at the level of noncyclic isoprenoids such as geranoyl-CoA, which can be catabolized by Pseudomonas citronellolis and plants by a series of reactions also leading to 3-methylcrotonyl-CoA (31, 32) (Fig. 1) .
Microbial or plant mutants or human patients specifically deficient in this pathway have not yet been reported, nor have animal models been devised. In view of the apparent similarity between fungal and human leucine degradation pathways, we used our fungal model deficient in MCC to obtain genetic evidence for the existence of this link, using the GC/MS procedure described above. Whereas the metabolic profile of the wild type culture supernatant was markedly similar to that of a ⌬mccA ⌬mccB strain when transferred to medium with 0.05% (w/v) lactose as the sole carbon source (Fig. 8, A and B) , the mutant specifically accumulated 3-HIVA on transfer to acetate medium (Fig. 8, C and D) (acetate is converted to acetyl-CoA by acetyl-CoA synthetase (33) ). This finding agrees with the existence of the above mentioned link, since among compounds directly derived from acetyl-CoA only isoprenoid biosynthesis intermediates can be converted to a ␤-methyl branched compound such as 3-methylcrotonyl-CoA. Marked accumulation of 3-HIVA in the mutant but not in the wild type supernatant was also observed upon transfer to the mevalonate precursor 3-hydroxy-3-methylglutaric acid (Fig. 8, E and F) . Moreover, despite the apparently inefficient utilization of mevalonate by A. nidulans, the MCC-deficient mutant but not the wild type clearly accumulated 3-HIVA upon transfer to mevalonate (a 2 J. M. Rodríguez and M. A. Peñ alva, unpublished results.
FIG. 5. Northern analysis of mutant mcc strains. Shown is
Northern blot analysis of RNA isolated from strains with the indicated relevant genotype, using probes specific for the genes indicated on the right of each panel. Mycelia were cultured under Leu-inducing conditions as in Fig. 2 . Approximately equal amounts of total RNA were loaded on each track, as determined by ethidium bromide staining of rRNAs (not shown). commercial preparation that is a mixture of D-and L-isomers with mevalolactone (Fig. 8, G and H) ). These results strongly support the existence of a mevalonate shunt in A. nidulans.
DISCUSSION
Our work has pioneered the use of A. nidulans knock-out strains as fungal models for human inborn errors of metabo- FIG. 6 . GC/MS analysis of culture supernatants of MCC-deficient strains. A and B, GC/MS analyses of urinary organic acids from a normal individual or from a patient suffering from isolated 3-methylcrotonyl-CoA carboxylase deficiency. C-H, A. nidulans wild-type or mutant ⌬mccA ⌬mccB strains were precultured as for Northern analysis and transferred to fresh media with the indicated carbon sources, where they were incubated for a further 21 h before analyzing organic acids extracted from culture supernatants by GC/MS. Lactose was used at 0.05% (w/v), Leu was used at 3 mM, and Ile was used at 10 mM (Ile is a poorer carbon source than Leu). Phenylacetic acid (PhAc) was added exogenously to culture supernatants and served as an internal control for the extraction procedure. Ethylvanilline (EV) was used as control for derivatization. 2HIC, 2-hydroxyisocaproic acid; MC, methylcrotonic acid; 2H3MV, 2-hydroxy-3-methylvaleric acid. 3-HIVA is the marker of the MCC deficiency.
lism (11-13) (this work). Of particular note, we found that enzymes for A. nidulans amino acid catabolism are ϳ50% identical in amino acid sequence to their human homologues, a finding that has been crucial for the identification of as yet uncharacterized human amino acid catabolism genes by in silico searches of human data bases (for a review, see Ref. 34) . This approach was successfully exploited in the characterization of the human genes for alkaptonuria (12, 13, 35, 36) , maleylacetoacetate isomerase deficiency (13) , and 3-methylcrotonyl-CoA carboxylase deficiency (3). Alkaptonuria, Garrod's prototypic inborn error of metabolism and the first human disease to be recognized as a Mendelian trait (37, 38) , is a notable example of a gene that was first characterized using our fungal model, despite the facts that the human gene had previously been genetically mapped (39) and a mouse model was available (40) .
We report here the genetic and biochemical characterization of fungal models for 3-methylcrotonyl-CoA carboxylase deficiency. Fungal cell models for inborn errors of Leu metabolism are particularly advantageous over human cell models for two reasons. First, Leu metabolism involves extensive interplay of metabolites between muscle and liver as a result of nonuniform distribution of BCAA transaminase (which is high in muscle and low in liver) and BCKA dehydrogenase (which is low in muscle and high in liver) (2) , complicating the use of a single human cell type. Second, Leu, which is catabolized to acetylCoA and acetoacetate, is a ketogenic amino acid in humans/ mammals. In contrast, A. nidulans can convert acetyl-CoA into carbohydrates through the glyoxylate bypass of the Krebs cycle (41) (42) (43) (44) . Therefore, the fungus can use Leu as sole carbon source and simple growth tests can be used to determine whether mutations impair the catabolic pathway (see Fig. 7 ). Results reported here together with data in Ref 3 show that null mutations in either of the genes encoding MCC subunits prevent growth on Leu but have no effect on utilization other amino acids, formally demonstrating that MCC is specifically involved in Leu catabolism in vivo.
Since expression of the metabolic defect in Aspergillus mutants is dependent upon the presence of the pathway substrate, cells can be precultured using carbohydrates and challenged by the pathway substrate simply by transferring mycelia to fresh medium. Metabolites accumulating as a result of the metabolic block leak into the medium and can be analyzed by high pressure liquid chromatography or GC/MS. These studies revealed that fungal amino acid catabolism models faithfully resemble most aspects of the biochemical phenotype in human patients. For example, the fungal alkaptonuric model accumulated the ochronotic pigment (12) , and the fungal model for type 1 tyrosinemia accumulated succinylacetone, the diagnostic compound of the disease in the urine of human patients (11) .
When cultured in the presence of Leu, MCC-deficient strains accumulate 3-HIVA in the culture supernatant, as determined by GC/MS. 3-HIVA is one of the diagnostic compounds in the urine of MCC-deficient patients, strongly supporting the validity of the metabolic model. In the presence of lactose as the sole carbon source, the addition of Leu impairs growth of MCCdeficient strains to a significant extent, strongly indicating that one or more of the metabolites accumulating in the mutants are toxic to the cells. One possibility is that high levels of 3-HIVA accumulating in the mitochondria affect its normal functioning. A. nidulans is an aerobe, and therefore its growth rate is highly dependent on normal mitochondrial function. Accumulation of 3-HIVA in the culture supernatant of the MCC-deficient strains is indicative of metabolite flow through the Leu degradation pathway. Growth of these strains on 0.05% lactose results in a minor yet detectable accumulation of 3-HIVA, possibly reflecting that such growth conditions result in carbon source limitation that triggers catabolism of amino acids resulting from protein turnover. The levels of 3-HIVA detected upon transfer of a MCC-deficient strain to Ile were similar to those on lactose, strongly indicating that Ile catabolism does not produce shunt metabolites that can be converted into 3-methylcrotonyl-CoA.
In humans, as much as 16.5% of mevalonate is diverted away from sterol biosynthesis (45) . Both the mevalonate shunt proposed by Edmond and Popjá k (29) and the geranoyl-CoA catabolic pathway proposed in bacteria (31) and plants (32) involve the three final steps of Leu catabolism in the conversion of isopentenyl pyrophosphate and geranoyl-CoA, respectively, into acetoacetate and acetyl-CoA. Therefore, if either or both were operative in Aspergillus, MCC-deficient strains should predictably accumulate 3-HIVA upon exposure to isoprenoid precursors. 3HMG-CoA is the immediate precursor of mevalonate, the building block of isoprenoids. The high levels of 3-HIVA found in culture supernatants of the double mcc null mutant upon transfer to a medium containing 3HMG strongly indicate that a fraction of the 3HMG pool is converted into metabolites of the lower Leu catabolic pathway through isopentenyl pyrophosphate or linear isoprenoids. The finding that 3-HIVA was also detected in the mutant culture supernatant upon transfer to mevalonate strongly supports this interpretation.
A link between sterol biosynthesis and Leu catabolism is also suggested by certain biochemical findings detected in patients with Smith-Lemli-Opitz syndrome (OMIM 270400) (46) who, as a result of a deficiency of a cholesterol biosynthetic enzyme, are likely to accumulate high levels of cholesterol precursors. Patients with the lowest cholesterol levels show abnormally increased plasma levels of 3-methylglutaconic acid, as would be expected if forced flow through the mevalonate/isoprenoid shunt strains 3-MG-CoA hydratase, the enzyme downstream of MCC (47) . Our work provides the first reported genetic evidence for the mevalonate/isoprenoid shunt, whose precise enzymatic basis remains to be determined.
MCC is a member of the biotin-dependent carboxylase family of enzymes. In Escherichia coli ACC, the biotin-carboxylating, biotin carrier, and carboxyltransferase domains reside in three different polypeptide chains, in contrast to fungal and mammalian ACCs, where all three activities reside in a single polypeptide. MCC and PCC display an intermediate organization. They are ␣/␤ heteromeric complexes, where ␣ subunits contain an N-terminal biotin-carboxylating domain and a smaller, C-terminal biotin carboxyl carrier domain separated by a relatively long nonconserved arm. The carboxyltransferase domain is located in the ␤ subunits, where substrate specificity resides. The high level of identity between the catalytic domains of PCC␣ and MCC␣ would suggest the possibility that FIG. 7 . Leucine toxicity to MCC-deficient strains. Wild-type (wt) and mutant strains were inoculated onto minimal medium plates containing the indicated carbon sources and incubated at 37°C for 5 days. A. nidulans wild-type or mutant ⌬mccA ⌬mccB strains were precultured as in Fig. 6 before analyzing organic acids extracted from culture supernatants by GC/MS. Carbon compounds were used as follows: lactose at 0.05% (w/v), acetate at 100 mM, 3-hydroxy-3-methylglutarate and mevalonate at 30 mM. Phenylacetic acid (PhAc) was added exogenously to culture supernatants and served as an internal control for the extraction procedure. Ethylvanilline (EV) was used as control for derivatization. Their peaks are not visible in the mevalonate conditions, as for G and H we injected one-fortieth of the material used for A-F, due to the fact that mevalonate appears to be inefficiently taken up by A. nidulans, which results in column saturation. 3H3MV, 3-hydroxy-3-methylvaleric acid, almost certainly proceeding from mevalonate. 2-HIVA, 2-hydroxyisovaleric acid. | and }, succinic and fumaric acids, respectively. MVA, DL-mevalonic acid; MVL, mevalolactone.
PCC␣ could at least partially substitute for MCC␣ in vivo. We show that ⌬mccA, ⌬mccB, and ⌬mccA ⌬mccB strains are phenotypically indistinguishable in their inability to grow on Leu and their nearly undetectable in vitro MCC activity. These findings rule out the above possibility and suggest that the interaction between ␣ modules and their corresponding ␤ subunits is specific. The structures of the biotin-carboxylating (5, 20) and biotin carrier domains (48) of E. coli ACC, the carboxyltransferase domain of yeast ACC (49) , and the Propionibacterium shermanii transcarboxylase (50) have been determined. However, the structural determinants of the specific ␣/␤ interaction in PCC and MCC and the basis for substrate discrimination by their ␤ subunits remain to be described.
